Interview with Michaela A. Dinan, PhD, author of Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"JAMA Oncology Author Interviews","authorlink":""},"src":"http:\/\/traffic.libsyn.com\/jamaoncologyauthorinterviews\/21-Gene_Recurrence_Score_Assay_for_Breast_Cancer_JAMA_Oncology.mp3?dest-id=422099","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202106\/a8e7a4-08a5-b82b-31c61a_800.jpg"},"title":"21-Gene Recurrence Score Assay for Breast Cancer","link":"javascript:;","id":"item-438034"}]
